BRCA Rules Leave Patients Behind

Meir Rinde
Published: Friday, Nov 01, 2019
Allison Kurian, MD, MSc, director of the Stanford Womens Clinical Cancer Genetics Program at Stanford University

Allison Kurian, MD, MSc

Updated guidelines from the United States Preventive Services Task Force (USPSTF) on BRCA1/2 genetic testing recommend risk assessment, counseling, and genetic testing for women who meet certain criteria but fall short of encompassing important groups of individuals who are at risk for developing BRCA1/2 mutation–driven disease, according to critics of the update.

DNA-repair genes remains underused even among patients who have had those cancers more recently.

Figure 1. Updated USPSTF Guideline Leaves Out Key Populations

Figure 1. Updated USPSTF Guideline Leaves Out Key Populations
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication
x